RecruitingPhase 3NCT07667803
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Sponsor: AstraZeneca
Melrose Park, IL · +55 more sites
2 recruiting obesity studies with a site in Melrose Park, IL.
Sponsor: AstraZeneca
Melrose Park, IL · +55 more sites
Sponsor: AstraZeneca
Chicago, IL · Melrose Park, IL · +52 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.